These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 21673342)
1. DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by γδ T lymphocytes. Nussbaumer O; Gruenbacher G; Gander H; Thurnher M Blood; 2011 Sep; 118(10):2743-51. PubMed ID: 21673342 [TBL] [Abstract][Full Text] [Related]
3. Essential requirements of zoledronate-induced cytokine and γδ T cell proliferative responses. Nussbaumer O; Gruenbacher G; Gander H; Komuczki J; Rahm A; Thurnher M J Immunol; 2013 Aug; 191(3):1346-55. PubMed ID: 23794630 [TBL] [Abstract][Full Text] [Related]
4. IL-2 costimulation enables statin-mediated activation of human NK cells, preferentially through a mechanism involving CD56+ dendritic cells. Gruenbacher G; Gander H; Nussbaumer O; Nussbaumer W; Rahm A; Thurnher M Cancer Res; 2010 Dec; 70(23):9611-20. PubMed ID: 20947520 [TBL] [Abstract][Full Text] [Related]
5. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate. Watanabe N; Narita M; Yokoyama A; Sekiguchi A; Saito A; Tochiki N; Furukawa T; Toba K; Aizawa Y; Takahashi M Cytotherapy; 2006; 8(2):118-29. PubMed ID: 16698685 [TBL] [Abstract][Full Text] [Related]
6. Expansion of human peripheral blood γδ T cells using zoledronate. Kondo M; Izumi T; Fujieda N; Kondo A; Morishita T; Matsushita H; Kakimi K J Vis Exp; 2011 Sep; (55):. PubMed ID: 21931292 [TBL] [Abstract][Full Text] [Related]
7. Effect of IL-18 on expansion of gammadelta T cells stimulated by zoledronate and IL-2. Li W; Kubo S; Okuda A; Yamamoto H; Ueda H; Tanaka T; Nakamura H; Yamanishi H; Terada N; Okamura H J Immunother; 2010 Apr; 33(3):287-96. PubMed ID: 20445349 [TBL] [Abstract][Full Text] [Related]
8. Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid. Fiore F; Castella B; Nuschak B; Bertieri R; Mariani S; Bruno B; Pantaleoni F; Foglietta M; Boccadoro M; Massaia M Blood; 2007 Aug; 110(3):921-7. PubMed ID: 17403919 [TBL] [Abstract][Full Text] [Related]
9. [Effect of zoledronate on the cytotoxicity of γδ T cells from PBMCs of osteosarcoma patients against osteosarcoma]. Li Z; Tang J; Sun L; Ye Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):6-9. PubMed ID: 23294710 [TBL] [Abstract][Full Text] [Related]
10. [Amplification of γδ T cells in PBMCs of healthy donors and osteosarcoma patients stimulated by zoledronate]. Li ZX; Sun LL; Cheng RL; Sun ZW; Ye ZM Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):822-4. PubMed ID: 22863589 [TBL] [Abstract][Full Text] [Related]
11. Zoledronate promotes inflammatory cytokine expression in human CD14-positive monocytes among peripheral mononuclear cells in the presence of γδ T cells. Takimoto R; Suzawa T; Yamada A; Sasa K; Miyamoto Y; Yoshimura K; Sasama Y; Tanaka M; Kinoshita M; Ikezaki K; Ichikawa M; Yamamoto M; Shirota T; Kamijo R Immunology; 2021 Mar; 162(3):306-313. PubMed ID: 33131052 [TBL] [Abstract][Full Text] [Related]
12. Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Dieli F; Vermijlen D; Fulfaro F; Caccamo N; Meraviglia S; Cicero G; Roberts A; Buccheri S; D'Asaro M; Gebbia N; Salerno A; Eberl M; Hayday AC Cancer Res; 2007 Aug; 67(15):7450-7. PubMed ID: 17671215 [TBL] [Abstract][Full Text] [Related]
13. Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity. Poonia B; Pauza CD Cytotherapy; 2012 Feb; 14(2):173-81. PubMed ID: 22029653 [TBL] [Abstract][Full Text] [Related]
14. Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cells. Castella B; Riganti C; Fiore F; Pantaleoni F; Canepari ME; Peola S; Foglietta M; Palumbo A; Bosia A; Coscia M; Boccadoro M; Massaia M J Immunol; 2011 Aug; 187(4):1578-90. PubMed ID: 21753152 [TBL] [Abstract][Full Text] [Related]
15. Regulation of development of CD56 bright CD11c + NK-like cells with helper function by IL-18. Li W; Okuda A; Yamamoto H; Yamanishi K; Terada N; Yamanishi H; Tanaka Y; Okamura H PLoS One; 2013; 8(12):e82586. PubMed ID: 24376549 [TBL] [Abstract][Full Text] [Related]
16. Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes. Serrano R; Wesch D; Kabelitz D Cells; 2020 Mar; 9(3):. PubMed ID: 32183240 [TBL] [Abstract][Full Text] [Related]
17. Lower concentrations of methyl-β-cyclodextrin combined with interleukin-2 can preferentially induce activation and proliferation of natural killer cells in human peripheral blood. Lü HZ; Zhu AY; Chen Y; Tang J; Li BQ Hum Immunol; 2011 Jul; 72(7):538-46. PubMed ID: 21540068 [TBL] [Abstract][Full Text] [Related]
18. Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. Conti L; Casetti R; Cardone M; Varano B; Martino A; Belardelli F; Poccia F; Gessani S J Immunol; 2005 Jan; 174(1):252-60. PubMed ID: 15611247 [TBL] [Abstract][Full Text] [Related]
19. Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP. Roelofs AJ; Jauhiainen M; Mönkkönen H; Rogers MJ; Mönkkönen J; Thompson K Br J Haematol; 2009 Jan; 144(2):245-50. PubMed ID: 19016713 [TBL] [Abstract][Full Text] [Related]
20. Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γ. Sarhan D; D'Arcy P; Wennerberg E; Lidén M; Hu J; Winqvist O; Rolny C; Lundqvist A Eur J Immunol; 2013 Jan; 43(1):249-57. PubMed ID: 22996291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]